Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years—reflecting increased use of new medications under Medicare Part D, reports a study in Urology Practice.
Dec 20, 2022
0
0
More than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the disease remain unexplored for the majority of patients around the world. In the final days of the Movember ...
Nov 28, 2022
0
2
Despite having lived with five different cancers over the last two decades—prostate, thyroid, kidney, appendix, and skin—Joel Nowak doesn't consider himself a "survivor." Rather, as a self-described "cancer thriver," ...
Aug 22, 2022
0
7
As the cost of genome and exome sequencing falls, its use in characterizing rare diseases and personalizing cancer treatment, for example, is becoming far more frequent. But such analyses may throw up findings unrelated to ...
Jun 10, 2022
0
17
Hormone therapy is often used to treat prostate cancer that has spread to other parts of the body, but many patients develop resistance to hormone therapy, causing their disease to become more aggressive and potentially more ...
May 10, 2022
0
34
Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate ...
Apr 22, 2022
0
19
(HealthDay)—There were large temporal changes in screening, biopsy, overall cancer detection, and metastatic cancer rates following the 2012 U.S. Preventive Services Task Force (USPSTF) Prostate Cancer Screening Statement, ...
Dec 22, 2021
0
5
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
Sep 23, 2021
0
9
A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according to late breaking research presented at the ESMO Congress 2021. The PEACE-1 and STAMPEDE studies ...
Sep 20, 2021
0
0
An international team led by researchers from Tampere University and the University of Eastern Finland has discovered how comparing genomic changes in cancer cells that are eradicated by and resistant to treatment can be ...
Sep 10, 2021
0
69
